Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma

The Measurement of Observer Agreement for Categorical Data

J. Richard Landis, Gary G. Koch · Biometrics · 1977 · 78.9K citations · Full text

Public Health, Biostatistics, Categorical Data Analysis +12

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · Journal of Clinical Oncology · 2009 · 2.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

Robert J. Motzer, Jennifer Bacik, Barbara A. Murphy et al. · Journal of Clinical Oncology · 2002 · 1.5K citations

Medicine, Oncology, Pharmacotherapy +17

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · The Lancet Oncology · 2013 · 1K citations · Full text

Medicine, Biostatistics, Oncology +14

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

Daniel Keizman, Maya Ish‐Shalom, Peng Huang et al. · European Journal of Cancer · 2011 · 213 citations

Medicine, Oncology, Pharmacology +12